Amid the race to develop and distribute a potential coronavirus vaccine, Russia on Tuesday announced that its Sputnik V covid-19 vaccine is 95% effective and will be charged less than rival vaccines as Moscow aims to produce more than 1 billion doses at home and abroad next year.
Cost of Russia’s two-shot Sputnik V vaccine will be less than $20 per person for international markets with each shot costing less than $10. informed Russian sovereign wealth fund.
The head of Russia’s sovereign wealth fund said Kirill Dmitriev told Reuters that new clinical trial data based on 39 confirmed cases and 18,794 patients who got both shots had shown that Sputnik V was 91.4% effective on day 28 and over 95% effective on day 42. No adverse side-effects reported during the trial, reports said.
The total number of cases in the state is now 10,931 including 1,471 active cases and 9,291 recovered cases, he said.
The statement said that 22,000 volunteers had been vaccinated with the first dose and more than 19,000 with both doses.
On August 11, the Sputnik V vaccine was registered by the Ministry of Health of Russia and became the world’s first registered vaccine against COVID-19 based on the human adenoviral vector platform.
On Monday, British-Swedish drugmaker AstraZeneca said its covid vaccine for the novel coronavirus, developed along with the University of Oxford, could be around 90% effective under one dosing regimen. On November 17, Moderna, in its official statement, had announced that the independent, U.S. NIH-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of mRNA-1273 has informed Moderna that the trial has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%.
Overseas trials of the vaccine are also taking place in the United Arab Emirates, Venezuela, Belarus and other countries.
Russia in August became the first country to register a coronavirus vaccine but did so ahead of the large-scale clinical trials that are still underway.
Last month, President Vladimir Putin announced that Russia had registered a second coronavirus vaccine, EpiVacCorona, as a global race heats up in producing an effective vaccine to combat the pandemic, which has now claimed the lives of nearly 1.4 million people.
Putin last week said that Russia had manufacturing agreements in place with China and India and encouraged Brazil and South Africa to also mass produce Russian-made vaccines.
The pricing announcement comes as Russia looks to scale up distribution and production. Kirill Dmitriev, head of Russia’s RDIF sovereign wealth fund, said Moscow and its foreign partners had capacity to make more than a billion doses starting from next year, enough to vaccinate over 500 million people.
The international market price for Sputnik V unveiled on Tuesday is cheaper than some other Western rivals such as a vaccine produced by Pfizer-BioNTech, which costs 15.5 euros per shot, but more expensive that a vaccine produced by AstraZeneca which will be sold in Europe for around 2.5 euros per shot.
- 1,500 Oxford Vaccine Trial Volunteers Given Wrong Dose, Kept In Dark About Error - February 2, 2021
- Kangana Ranaut Summoned By Mumbai Court In Javed Akhtar Defamation Case - February 2, 2021
- Iron bars hooked between barriers, cement poured in to create makeshift wall at Singhu border - February 2, 2021